1. Home
  2. HIX vs EBS Comparison

HIX vs EBS Comparison

Compare HIX & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Western Asset High Income Fund II Inc.

HIX

Western Asset High Income Fund II Inc.

N/A

Current Price

$3.32

Market Cap

351.3M

Sector

Finance

ML Signal

N/A

Logo Emergent Biosolutions Inc.

EBS

Emergent Biosolutions Inc.

N/A

Current Price

$5.16

Market Cap

303.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HIX
EBS
Founded
1998
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
351.3M
303.3M
IPO Year
1998
2006

Fundamental Metrics

Financial Performance
Metric
HIX
EBS
Price
$3.32
$5.16
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $10.00
AVG Volume (30 Days)
395.8K
★ 917.9K
Earning Date
01-01-0001
11-02-2026
Dividend Yield
★ 13.14%
N/A
EPS Growth
N/A
★ 125.83
EPS
★ N/A
N/A
Revenue
N/A
★ $742,900,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$7.03
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$3.34
$4.36
52 Week High
$4.33
$14.06

Technical Indicators

Market Signals
Indicator
HIX
EBS
Relative Strength Index (RSI) 35.12 28.53
Support Level N/A $4.36
Resistance Level $4.04 $7.18
Average True Range (ATR) 0.05 0.44
MACD -0.01 -0.09
Stochastic Oscillator 6.52 5.06

Price Performance

Historical Comparison
HIX
EBS

About HIX Western Asset High Income Fund II Inc.

Western Asset High Income Fund II Inc is a diversified closed-end management investment company. Its primary investment objective is to maximize current income by investing at least 80% of its net assets, plus any borrowings for investment purposes, in high-yield debt securities. As a secondary objective, the Fund seeks capital appreciation to the extent consistent with its objective of seeking to maximize current income.

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Share on Social Networks: